We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
GeneDx Holdings
WGS
$1.85B
| $341K | ﹤0.01% |
+4,973
| New | +$283K |
2026 Q2
0 quarters
|
|
3477
iShares Emerging Markets Equity Factor ETF
EMGF
$1.82B
| $340K | ﹤0.01% |
4,647
+175
| +4% | +$12.2K |
2026 Q1
1 quarter
|
|
3478
iShares MSCI Mexico ETF
EWW
$1.52B
| $340K | ﹤0.01% |
4,514
+816
| +22% | +$63.3K |
2025 Q2
4 quarters
|
|
3479
Nathan's Famous
NATH
$418M
| $339K | ﹤0.01% |
+3,341
| New | +$338K |
2026 Q2
0 quarters
|
|
3480
Banner Corp
BANR
$2.59B
| $339K | ﹤0.01% |
+5,106
| New | +$332K |
2026 Q2
0 quarters
|
|
3481
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.01B
| $339K | ﹤0.01% |
35,050
-6,880
| -16% | -$64.3K |
2015 Q3
43 quarters
|
|
3482
Lexeo Therapeutics
LXEO
$222M
| $338K | ﹤0.01% |
72,625
+5,546
| +8% | +$30K |
2025 Q4
2 quarters
|
|
3483
FIS Bright Portfolios Focused Equity ETF
BRIF
$159M
| $338K | ﹤0.01% |
+9,086
| New | +$310K |
2026 Q2
0 quarters
|
|
3484
Teekay Tankers
TNK
$3.53B
| $337K | ﹤0.01% |
5,202
+983
| +23% | +$74K |
2026 Q1
1 quarter
|
|
3485
Forward Air
FWRD
$514M
| $337K | ﹤0.01% |
24,955
-8,940
| -26% | -$133K |
2022 Q4
14 quarters
|
|
3486
Willdan Group
WLDN
$1.11B
| $337K | ﹤0.01% |
4,256
-73
| -2% | -$6.22K |
2025 Q3
3 quarters
|
|
3487
AbCellera Biologics
ABCL
$3.93B
| $336K | ﹤0.01% |
42,828
-1,223
| -3% | -$5.98K |
2024 Q3
7 quarters
|
|
3488
Distribution Solutions Group
DSGR
$1.62B
| $335K | ﹤0.01% |
12,250
+3,446
| +39% | +$94.1K |
2026 Q1
1 quarter
|
|
3489
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$687M
| $334K | ﹤0.01% |
+11,527
| New | +$318K |
2026 Q2
0 quarters
|
|
3490
iShares MSCI Peru and Global Exposure ETF
EPU
$519M
| $334K | ﹤0.01% |
4,002
| – | – |
2026 Q1
1 quarter
|
|
3491
Obsidian Energy
OBE
$798M
| $334K | ﹤0.01% |
41,100
+50
| +0.1% | +$561 |
2024 Q3
7 quarters
|
|
3492
iShares Currency Hedged MSCI ACWI ex US ETF
HAWX
$351M
| $334K | ﹤0.01% |
7,183
| – | – |
2026 Q1
1 quarter
|
|
3493
BNY Mellon Municipal Intermediate ETF
BKMI
$1.64B
| $334K | ﹤0.01% |
12,621
| – | – |
2026 Q1
1 quarter
|
|
3494
Global X FinTech ETF
FINX
$153M
| $334K | ﹤0.01% |
+13,515
| New | +$337K |
2026 Q2
0 quarters
|
|
3495
Costamare Bulkers Holdings
CMDB
$493M
| $333K | ﹤0.01% |
18,964
-2,383
| -11% | -$41.4K |
2025 Q4
2 quarters
|
|
3496
Neurogene
NGNE
$472M
| $333K | ﹤0.01% |
+10,581
| New | +$291K |
2026 Q2
0 quarters
|
|
3497
Viridian Therapeutics
VRDN
$2.61B
| $333K | ﹤0.01% |
18,108
+5,007
| +38% | +$80.7K |
2025 Q2
4 quarters
|
|
3498
FundX Conservative ETF
XRLX
$46.2M
| $332K | ﹤0.01% |
6,719
| – | – |
2023 Q4
10 quarters
|
|
3499
Clearfield
CLFD
$397M
| $332K | ﹤0.01% |
8,347
-5,455
| -40% | -$200K |
2025 Q2
4 quarters
|
|
3500
Hello Group
MOMO
$641M
| $331K | ﹤0.01% |
57,096
+26,789
| +88% | +$160K |
2022 Q4
14 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.